BIOTON S.A. (WSE:BIO)
3.845
0.00 (0.00%)
Jul 24, 2026, 5:00 PM CET
BIOTON Balance Sheet
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 2.61 | 8.28 | 6.96 | 3.88 | 9.34 | 8.86 |
Cash & Short-Term Investments | 2.61 | 8.28 | 6.96 | 3.88 | 9.34 | 8.86 |
Cash Growth | -4.64% | 18.96% | 79.32% | -58.42% | 5.44% | -60.17% |
Accounts Receivable | 37.99 | 37.77 | 34.69 | 42.76 | 31.4 | 39.11 |
Other Receivables | - | - | 0.03 | 0.07 | 0 | 0.55 |
Total Trade Receivables | 37.99 | 37.77 | 34.71 | 42.84 | 31.41 | 39.65 |
Inventory | 105.19 | 95.01 | 107.29 | 118.2 | 111 | 125.13 |
Other Current Assets | 6.51 | 4.05 | 5.03 | 1.84 | 1.32 | 1.09 |
Total Current Assets | 152.3 | 145.11 | 154 | 166.76 | 153.07 | 174.73 |
Net Property, Plant & Equipment | 292.66 | 292.31 | 302.32 | 291.3 | 1.36 | 1.36 |
Other Intangible Assets | 323.49 | 327.06 | 337.73 | 363.88 | 362.98 | 362.18 |
Other Long-Term Assets | 0.08 | 0.09 | 0.09 | 0.28 | 0.82 | 6.3 |
Total Assets | 768.53 | 764.56 | 794.14 | 822.22 | 808.4 | 848.13 |
Accounts Payable | 42.69 | 32.37 | 53.04 | 54.13 | 36.1 | 36.93 |
Accrued Expenses | 3.03 | 2.89 | 2.3 | 2.27 | 2.22 | - |
Short-Term Debt | - | - | - | - | - | 13.81 |
Current Portion of Long-Term Debt | 32.54 | 32.15 | 36.96 | 52.85 | 55.31 | 64.81 |
Current Portion of Leases | 4.73 | 4.09 | 5.91 | 3.16 | 2.43 | 1.99 |
Other Current Liabilities | 29.49 | 31.41 | 44.9 | 53.18 | 45.01 | 48.52 |
Total Current Liabilities | 112.47 | 102.91 | 143.12 | 165.59 | 141.05 | 166.07 |
Long-Term Debt | 6.59 | 7.27 | - | 1.7 | 6.81 | 16.05 |
Long-Term Leases | 14.89 | 13.64 | 13.7 | 10.98 | 11.85 | 13.41 |
Other Long-Term Liabilities | 45.8 | 46.76 | 46.77 | 37.6 | 44.56 | 48.09 |
Total Long-Term Liabilities | 67.29 | 67.68 | 60.47 | 50.28 | 63.21 | 77.54 |
Total Liabilities | 179.75 | 170.59 | 203.59 | 215.87 | 204.27 | 243.61 |
Common Stock | 1,717 | 1,717 | 1,717 | 1,717 | 1,717 | 1,717 |
Additional Paid-in Capital | 317.91 | 317.91 | 317.91 | 317.91 | 317.91 | 317.91 |
Accumulated Other Comprehensive Income | -347.36 | -347.43 | -347.46 | -347.31 | -347.25 | -347.38 |
Retained Earnings | -1,099 | -1,094 | -1,097 | -1,082 | -1,084 | -1,083 |
Total Common Shareholders' Equity | 588.77 | 593.97 | 590.55 | 606.36 | 604.14 | 604.51 |
Shareholders' Equity | 588.77 | 593.97 | 590.55 | 606.36 | 604.14 | 604.51 |
Total Liabilities & Equity | 768.53 | 764.56 | 794.14 | 822.22 | 808.4 | 848.13 |
Total Debt | 58.75 | 57.16 | 56.57 | 68.69 | 76.39 | 110.08 |
Net Cash (Debt) | -56.14 | -48.88 | -49.61 | -64.81 | -67.05 | -101.22 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.65 | -0.57 | -0.58 | -0.76 | -0.78 | -1.18 |
Book Value | 588.77 | 593.97 | 590.55 | 606.36 | 604.14 | 604.51 |
Book Value Per Share | 6.86 | 6.92 | 6.88 | 7.06 | 7.04 | 7.04 |
Tangible Book Value | 265.29 | 266.91 | 252.82 | 242.48 | 241.16 | 242.34 |
Tangible Book Value Per Share | 3.09 | 3.11 | 2.94 | 2.82 | 2.81 | 2.82 |